The DOI matches its Crossref record.
Identification and Characterization of Novel Inhibitors of Mammalian Aspartyl Aminopeptidase
Open accessAbstract
Aspartyl aminopeptidase (DNPEP) has been implicated in the control of angiotensin signaling and endosome trafficking, but its precise biologic roles remain incompletely defined. We performed a high-throughput screen of ∼25,000 small molecules to identify inhibitors of DNPEP for use as tools to study its biologic functions. Twenty-three confirmed hits inhibited DNPEP-catalyzed hydrolysis of angiotensin II with micromolar potency. A counter screen against glutamyl aminopeptidase (ENPEP), an enzyme with substrate specificity similar to that of DNPEP, identified eight DNPEP-selective inhibitors. Structure-activity relationships and modeling studies revealed structural features common to the identified inhibitors, including a metal-chelating group and a charged or polar moiety that could interact with portions of the enzyme active site. The compounds identified in this study should be valuable tools for elucidating DNPEP physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRAT transfers the acyl chain exclusively from phosphatidylcholine onto vitamin A or closely related retinoid-like substrates.
“Instead, LRAT transfers the acyl chain exclusively from PC onto vitamin A or closely related retinoid-like substrates [40,43].”
From Molecular Basis for Vitamin A Uptake and Storage in Vertebrates (2016) · cites this paper as [43]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 49
- Baell, 2010, Observations on screening-based research and some concerning trends in the literature, Future Med Chem, 2, 1529, 10.4155/fmc.10.237 · DOI
- Baell, 2010, New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J Med Chem, 53, 2719, 10.1021/jm901137j · DOI
- Balavoine, 2014, Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase A inhibitor prodrug, Clin Pharmacokinet, 53, 385, 10.1007/s40262-013-0125-y · DOI
- Bishop, 2009, Brought to life: targeted activation of enzyme function with small molecules, J Chem Biol, 2, 1, 10.1007/s12154-008-0012-4 · DOI
- Bodineau, 2008, Aminopeptidase A inhibitors as centrally acting antihypertensive agents, Heart Fail Rev, 13, 311, 10.1007/s10741-007-9077-3 · DOI
- Bodineau, 2008, Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension, Hypertension, 51, 1318, 10.1161/HYPERTENSIONAHA.107.098772 · DOI
- Brunger, 2007, Version 1.2 of the crystallography and NMR system, Nat Protoc, 2, 2728, 10.1038/nprot.2007.406 · DOI
- Cai, 2010, Aspartyl aminopeptidase, encoded by an evolutionarily conserved syntenic gene, is colocalized with its cluster in secretory granules of pancreatic islet cells, Biosci Biotechnol Biochem, 74, 2050, 10.1271/bbb.100349 · DOI
- Carlson, 2006, Chemical probes of UDP-galactopyranose mutase, Chem Biol, 13, 825, 10.1016/j.chembiol.2006.06.007 · DOI
- Carter, 2001, Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha, Proc Natl Acad Sci USA, 98, 11879, 10.1073/pnas.211178398 · DOI
- Chai, 2010, A cell-based assay that targets methionine aminopeptidase in a physiologically relevant environment, Bioorg Med Chem Lett, 20, 2129, 10.1016/j.bmcl.2010.02.052 · DOI
- Chaikuad, 2012, Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family, BMC Struct Biol, 12, 14, 10.1186/1472-6807-12-14 · DOI
- Chen, 2012, Insights into substrate specificity and metal activation of mammalian tetrahedral aspartyl aminopeptidase, J Biol Chem, 287, 13356, 10.1074/jbc.M112.347518 · DOI
- Forino, 2005, Efficient synthetic inhibitors of anthrax lethal factor, Proc Natl Acad Sci USA, 102, 9499, 10.1073/pnas.0502733102 · DOI
- Glenner, 1962, A mammalian peptidase specific for the hydrolysis of N-terminal alpha-L-glutamyl and aspartyl residues, Nature, 194, 867, 10.1038/194867a0 · DOI
- Goto, 2006, Enzymatic properties of human aminopeptidase A: regulation of its enzymatic activity by calcium and angiotensin IV, J Biol Chem, 281, 23503, 10.1074/jbc.M603191200 · DOI
- Hoffman, 2009, Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5′-phosphate cofactor, J Med Chem, 52, 6032, 10.1021/jm900775q · DOI
- Hu, 2008, In situ “click” assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups, Org Lett, 10, 5529, 10.1021/ol802286g · DOI
- Larrinaga, 2013, Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer, Transl Res, 162, 297, 10.1016/j.trsl.2013.07.010 · DOI
- Li, 2013, Inactivation of Caenorhabditis elegans aminopeptidase DNPP-1 restores endocytic sorting and recycling in tat-1 mutants, Mol Biol Cell, 24, 1163, 10.1091/mbc.e12-10-0730 · DOI
- Lindquist, 1969, Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper, Arch Pathol, 87, 370
- Marc, 2012, Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats, Hypertension, 60, 411, 10.1161/HYPERTENSIONAHA.112.190942 · DOI
- Marchiò, 2004, Aminopeptidase A is a functional target in angiogenic blood vessels, Cancer Cell, 5, 151, 10.1016/S1535-6108(04)00025-X · DOI
- Martínez-Martos, 2011, Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer, Breast, 20, 444, 10.1016/j.breast.2011.04.008 · DOI
- Mast, 2014, Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice, J Biol Chem, 289, 3529, 10.1074/jbc.M113.532846 · DOI
- Mayas, 2012, Renin-angiotensin system-regulating aminopeptidases in tumor growth of rat C6 gliomas implanted at the subcutaneous region, Anticancer Res, 32, 3675
- Mayas, 2012, Influence of chronic ethanol intake on mouse synaptosomal aspartyl aminopeptidase and aminopeptidase A: relationship with oxidative stress indicators, Alcohol, 46, 481, 10.1016/j.alcohol.2011.10.005 · DOI
- Mendgen, 2012, Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry, J Med Chem, 55, 743, 10.1021/jm201243p · DOI
- Mitsui, 2003, Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice, Mol Med, 9, 57, 10.1007/BF03402108 · DOI
- Mucha, 2010, Metallo-aminopeptidase inhibitors, Biochimie, 92, 1509, 10.1016/j.biochi.2010.04.026 · DOI
- Nakamura, 2011, Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling, Mol Cell Biol, 31, 3019, 10.1128/MCB.05178-11 · DOI · Paper page
- Nanus, 1993, Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A, Proc Natl Acad Sci USA, 90, 7069, 10.1073/pnas.90.15.7069 · DOI
- Pérez, 2009, Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma, Head Neck, 31, 1335, 10.1002/hed.21099 · DOI
- Powers, 2006, SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase, J Med Chem, 49, 1034, 10.1021/jm050859x · DOI
- Rawlings, 2014, MEROPS: the database of proteolytic enzymes, their substrates and inhibitors, Nucleic Acids Res, 42, D503, 10.1093/nar/gkt953 · DOI
- Reaux, 1999, Aminopeptidase A inhibitors as potential central antihypertensive agents, Proc Natl Acad Sci USA, 96, 13415, 10.1073/pnas.96.23.13415 · DOI
- Simeonov, 2008, Fluorescence spectroscopic profiling of compound libraries, J Med Chem, 51, 2363, 10.1021/jm701301m · DOI
- Sivaraman, 2012, X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP, J Mol Biol, 422, 495, 10.1016/j.jmb.2012.06.006 · DOI
- Soares, 2010, Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments, Assay Drug Dev Technol, 8, 152, 10.1089/adt.2009.0247 · DOI
- Stoermer, 2003, Synthesis and biological evaluation of hydroxamate-based inhibitors of glutamate carboxypeptidase II, Bioorg Med Chem Lett, 13, 2097, 10.1016/S0960-894X(03)00407-4 · DOI
- Teuscher, 2007, The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum, J Biol Chem, 282, 30817, 10.1074/jbc.M704938200 · DOI
- Tonna, 2008, Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS), Gene, 410, 44, 10.1016/j.gene.2007.11.014 · DOI
- Voss, 2003, Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonists, Bioorg Med Chem Lett, 13, 533, 10.1016/S0960-894X(02)00941-1 · DOI
- Wang, 2008, Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity, J Med Chem, 51, 6110, 10.1021/jm8005788 · DOI
- Wilk, 1998, Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase, J Biol Chem, 273, 15961, 10.1074/jbc.273.26.15961 · DOI
- Wright, 2003, Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats, Am J Physiol Regul Integr Comp Physiol, 284, R725, 10.1152/ajpregu.00326.2002 · DOI
- Wu, 1990, Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family, Proc Natl Acad Sci USA, 87, 993, 10.1073/pnas.87.3.993 · DOI
- Yang, 2013, Structural insights into central hypertension regulation by human aminopeptidase A, J Biol Chem, 288, 25638, 10.1074/jbc.M113.494955 · DOI
- Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J Biomol Screen, 4, 67, 10.1177/108705719900400206 · DOI · Paper page
Cited by
Sorted by citations
Molecular Basis for Vitamin A Uptake and Storage in Vertebrates
Chelstowska, S., Widjaja-Adhi, M., Silvaroli, J., & Golczak, M. (2016) · Nutrients · doi:10.3390/nu8110676 · Cited by 72
“Additionally, in terms of substrate specificity, LRAT activity is limited to retinol and its derivatives such as endogenous apo-carotenoids or xenobiotic retinylamine that share a common structural motif [42,43].”
Self-citation
Metadata
- Authors
- Chen, Y., Tang, H., Seibel, W., Papoian, R., Oh, K., Li, X., Zhang, J., Golczak, M., Palczewski, K., & Kiser, P. D.
- Affiliations
- Case Western Reserve University (US)
- ORCID
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 86
- Issue
- 2
- Pages
- 231-242
- ISSN
- 0026-895X (ISSN-L)
- PMC
- PMC4127928
- OpenAlex
- W2106600857
- Cited by
- 14
- References
- 0
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 1 · 2015: 2
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Case Western Reserve University
- School of Medicine, Case Western Reserve University
- National Institutes of Health (EY008061)
- National Eye Institute (EY-008061, R01EY008061)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- aspartyl aminopeptidase, enzyme inhibitors, glutamyl aminopeptidase, endosomal trafficking, small molecule screening, structure-activity relationship, active site interactions
- MeSH terms
- Angiotensin II, Animals, Enzyme Inhibitors, Humans, Hydrolysis, Mammals, Structure-Activity Relationship, Spodoptera, Catalytic Domain, Glutamyl Aminopeptidase, Sf9 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review